Latham & Watkins Honored With Five 2026 LMG Life Sciences Americas Awards
LMG Life Sciences, the premier legal rankings directory for the life sciences industry, has recognized Latham & Watkins across five categories in the 2026 Life Sciences Americas Awards. The awards honor the region’s leading practitioners and firms for outstanding work in the life sciences sector over the past 12 months.
This year, the firm received awards in the following categories:
- M&A Firm of the Year
- Securities Litigation Firm of the Year
- Corporate Attorney of the Year — Peter Handrinos
Additionally, Latham attorneys advised on two transactions named Impact Deal of the Year:
- Latham advised Kailera Therapeutics on its US$625 million IPO
- Latham advised Verona Pharma on its US$10 billion acquisition by Merck
Latham was also shortlisted across 11 other firm and individual categories, highlighting some of the industry’s most significant cases, transactions, and legal achievements.
Firm nominations:
- Life Cycle Firm of the Year
- Corporate Firm of the Year
- Licensing & Collaboration Firm of the Year
- Venture Capital Firm of the Year
- FDA Litigation & Enforcement Firm of the Year
- General Patent Litigation Firm of the Year
- Government Investigations Firm of the Year
Individual nominations:
- Venture Capital Attorney of the Year — Cheston Larson
- Regulatory Attorney of the Year: FDA Pharmaceutical — John Manthei
- FDA Litigation & Enforcement Attorney of the Year — Jennifer Bragg
- General Patent Litigator of the Year: DC Metro — Michael Morin
LMG Life Sciences is the only legal rankings directory focused exclusively on the life sciences sector, recognizing leading law firms and practitioners through rigorous analysis of business and legal developments across the industry. These honors reflect Latham's market-leading life sciences platform and the firm's ability to combine deep sector experience, legal excellence, and commercial insight to help clients navigate their most complex opportunities and challenges.